COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced that it will report its financial results for the third quarter ended September 30, 2011, on Friday, November 4, 2011. C. Randal Mills, Ph.D., President and Chief Executive Officer, and Philip R. Jacoby, Jr., Chief Financial Officer, will provide a company update and discuss results via a webcast and conference call on Friday, November 4, 2011 at 9:00 a.m. ET.
